Zalevsky Jonathan
Reporting owner on Forms 3, 4 and 5, CIK 1789857.
Zalevsky Jonathan reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NKTR · NEKTAR THERAPEUTICSCIK 906709 | officer (Chief R&D Officer) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NKTR · NEKTAR THERAPEUTICSCommon Stock | 2026-11-17 | S sold | -192 | $35.85 | 9,378 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468914 | NEKTAR THERAPEUTICS | 2026-11-19 |